Skip to Content

MYLAN TM 20 MYLAN TM 20 (Temozolomide 20 mg)

Pill with imprint MYLAN TM 20 MYLAN TM 20 is Yellow & White, Capsule-shape and has been identified as Temozolomide 20 mg. It is supplied by Mylan Pharmaceuticals Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN TM 20 MYLAN TM 20

Temozolomide 20 mg MYLAN TM 20 MYLAN TM 20

Temozolomide

Imprint
MYLAN TM 20 MYLAN TM 20
Strength
20 mg
Color
Yellow & White
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-5261
Inactive Ingredients
silicon dioxide, lactose anhydrous, sodium starch glycolate type A potato, stearic acid, tartaric acid, ammonia, ferrosoferric oxide, propylene glycol, shellac, gelatin, titanium dioxide, ferric oxide yellow, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.